Tirzepatide, a breakthrough medication for weight loss and diabetes management, has gained significant popularity in South Africa. However, with its growing demand comes the challenge of finding ...

Adults with obesity and a valid prescription can purchase 2.5 mg and 5 mg single-dose vials of tirzepatide. The single doses are available through a self-pay pharmacy component of LillyDirect.

The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and competitors such as Wegovy (semaglutide).

most compounded versions of tirzepatide come in vials, so patients should be especially careful with the source of their medication, she noted. Clinical trial data found that people using 5-mg ...

Eli Lilly and Company has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity. The move significantly expands the supply of ...

most compounded versions of tirzepatide come in vials, so patients should be especially careful with the source of their medication, she noted. Clinical trial data found that people using 5-mg ...